The identification of 2, 3-dihydroxybenzoic acid as a potentially useful iron-chelating drug

MeSH terms

• Administration, Oral
• Animals
• Ascorbic Acid / administration & dosage
• Ascorbic Acid / pharmacology
• Benzoates / adverse effects
• Blood Transfusion
• Body Weight / drug effects
• Calcium / urine
• Carboxylic Acids / administration & dosage
• Carboxylic Acids / pharmacology
• Carboxylic Acids / toxicity
• Catechols / administration & dosage
• Catechols / pharmacology*
• Catechols / toxicity
• Chelating Agents / adverse effects
• Copper / urine
• Deferoxamine / administration & dosage
• Deferoxamine / pharmacology
• Disease Models, Animal
• Feces / analysis
• Hemochromatosis / urine
• Hydroxylation
• Injections, Intraperitoneal
• Iron / analysis
• Iron / urine
• Iron Chelating Agents / administration & dosage
• Iron Chelating Agents / pharmacology*
• Iron Chelating Agents / toxicity
• Iron Radioisotopes
• Lethal Dose 50
• Magnesium / urine
• Mice
• Mice, Inbred Strains
• Rats
• Zinc / urine